IndietroIndietroUtile netto diluito per azionisti ordinari su ODI PHARMA AB BTA.
Dati annuali
−8,00 M
−6,00 M
−4,00 M
−2,00 M
0,00
Periodo
Valore
Variazione
Variazione %
TTM
−432,89 K
+135,17 K
+23,79%
2024
−568,06 K
+6,33 M
+91,77%
2023
−6,90 M
+337,90 K
+4,67%
2022
−7,24 M
−3,26 M
−81,81%
2021
−3,98 M
+980,55 K
+19,76%
2020
−4,96 M
−1,33 M
−36,60%
Dati trimestrali
Q2 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−2,60 M
−1,30 M
0,00
1,30 M
2,60 M
Periodo
Valore
Variazione
Variazione %
Q1 '25
−1,47 M
−259,27 K
−21,45%
Q4 '24
−1,21 M
−2,51 M
−193,16%
Q3 '24
1,30 M
+351,19 K
+37,10%
Q2 '24
946,53 K
+2,39 M
-
Q1 '24
−1,44 M
+1,09 M
+43,05%
Q4 '23
−2,53 M
−1,59 M
−168,28%
Q3 '23
−944,12 K
+791,70 K
+45,61%
Q2 '23
−1,74 M
−133,80 K
−8,35%